Medicine by Design researcher featured in media for MS Awareness month
Cutting-edge neural reprogramming strategy could transform the future of MS treatment
Cutting-edge neural reprogramming strategy could transform the future of MS treatment
The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.
Program selects inaugural incubator companies
Projects to impact autoimmune, intestinal and degenerative eye diseases
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.
Scientists at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, a method with the potential to accelerate treatments for diseases like muscular dystrophy.
Researchers have engineered a new method to improve the survival and potency of cell transplants to treat diabetes.
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
This “revolutionizing biology” offers the promise of new treatments for diseases and conditions including inflammatory bowel disease and autism spectrum disorder.
Cross-cutting research makes promising strides toward clinical testing
Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
Scientists can now select individual cells from their local environment & study their molecular contents. The new tool will enable a deeper study of stem cells and other rare cell types for diagnostics & therapy.